Ligand validation:8GN0

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GN0_GOL_B_648	94%	53%	0.077	0.976	0.89	0.94	-	-	0	0	100%	1
8GN0_GOL_a_2618	66%	50%	0.106	0.91	0.87	1.04	-	-	0	0	100%	1
8GN0_GOL_A_417	59%	50%	0.119	0.901	0.89	1.02	-	-	0	0	100%	1
8GN0_GOL_C_526	55%	46%	0.177	0.947	1.12	0.96	1	-	0	0	100%	1
8GN0_GOL_O_303	50%	52%	0.19	0.941	0.93	0.94	-	-	0	0	100%	1
8GN0_GOL_v_203	41%	46%	0.154	0.869	0.93	1.14	-	1	0	0	100%	1
8GN0_GOL_C_524	34%	53%	0.145	0.828	0.83	0.97	-	-	0	0	100%	1
8GN0_GOL_v_202	28%	51%	0.14	0.788	1.01	0.89	-	-	0	0	100%	1
8GN0_GOL_A_415	25%	51%	0.266	0.904	0.82	1.08	-	-	0	0	100%	1
8GN0_GOL_O_302	24%	49%	0.123	0.75	0.92	1.03	-	-	0	0	100%	1
8GN0_GOL_V_203	20%	53%	0.138	0.735	0.9	0.92	-	-	0	0	100%	1
8GN0_GOL_D_2301	19%	54%	0.222	0.815	1	0.79	-	-	0	0	100%	1
8GN0_GOL_a_2602	17%	51%	0.252	0.834	0.85	1.03	-	-	0	0	100%	1
8GN0_GOL_U_502	17%	46%	0.236	0.811	1.29	0.8	1	-	0	0	100%	1
8GN0_GOL_c_531	13%	53%	0.164	0.697	0.95	0.86	-	-	0	0	100%	1
8GN0_GOL_b_644	11%	50%	0.39	0.914	0.69	1.21	-	1	0	0	100%	1
8GN0_GOL_c_530	10%	56%	0.177	0.679	0.92	0.8	-	-	0	0	100%	1
8GN0_GOL_U_501	9%	50%	0.254	0.749	1.02	0.93	-	-	0	0	100%	1
8GN0_GOL_o_303	7%	51%	0.174	0.63	0.97	0.94	-	-	0	0	100%	1
8GN0_GOL_B_632	7%	52%	0.259	0.709	0.95	0.91	-	-	0	0	100%	1
8GN0_GOL_d_416	7%	51%	0.147	0.59	0.89	0.99	-	-	0	0	100%	1
8GN0_GOL_u_501	7%	46%	0.212	0.655	1.25	0.83	-	-	0	0	100%	1
8GN0_GOL_O_304	6%	52%	0.249	0.678	0.86	0.99	-	-	0	0	100%	1
8GN0_GOL_B_630	5%	51%	0.197	0.612	0.98	0.93	-	-	0	0	100%	1
8GN0_GOL_O_305	4%	54%	0.261	0.627	0.88	0.9	-	-	0	0	100%	1
8GN0_GOL_c_529	3%	51%	0.171	0.496	0.92	0.98	-	-	0	0	100%	1
8GN0_GOL_J_301	3%	52%	0.494	0.812	0.96	0.89	-	-	0	0	100%	1
8GN0_GOL_b_631	2%	57%	0.263	0.527	1.07	0.6	-	-	0	0	100%	1
8GN0_GOL_E_104	2%	52%	0.226	0.473	1	0.88	-	-	0	0	100%	1
8GN0_GOL_v_204	1%	52%	0.406	0.526	0.88	0.96	-	-	0	0	100%	1
5V2C_GOL_v_204	98%	47%	0.063	0.989	1.16	0.88	-	-	0	0	100%	1
6JLK_GOL_C_525	87%	81%	0.115	0.988	0.34	0.48	-	-	0	0	100%	1
6JLJ_GOL_C_526	87%	79%	0.117	0.988	0.34	0.52	-	-	0	0	100%	1
8IRB_GOL_C_523	86%	48%	0.091	0.958	1.18	0.83	-	-	0	0	100%	0.4
8IR9_GOL_C_523	84%	48%	0.097	0.96	1.18	0.83	-	-	0	0	100%	0.4
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.